Mavorixafor for Patients with Chronic Neutropenic Disorders Treated with G-CSF: Preliminary Response Data and G-CSF Dose Reduction in an Ongoing Phase 2, OpenLabel, Multicenter Study Support Reduction in G-CSF Dosing

被引：2
|
作者：
Warren, Julia T. [1 ,2 ]
Dickerson, Kathryn E. [3 ]
Sharathkumar, Anjali A. [4 ]
Walter, Jolan E. [5 ]
Wilson, David B. [6 ]
Adell, Katrina P. [7 ]
Chen, Kelly [7 ]
Dubuc, Susan [7 ]
MacLeod, Rick [7 ]
Peters, Katie [7 ]
Stewart, Murray [7 ]
Taveras, Arthur G. [7 ]
Walkovich, Kelly [8 ]
机构：
[1] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Div Hematol & Oncol, Dallas, TX 75390 USA
[4] Univ Iowa Hlth Care, Stead Family Dept Pediat, Carver Coll Med, Iowa City, IA USA
[5] Univ S Florida, Johns Hopkins All Childrens Hosp, Morsani Coll Med, Div Allergy & Immunol,Dept Pediat, St Petersburg, FL USA
[6] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA
[7] X4 Pharmaceut Inc, Boston, MA USA
[8] Univ Michigan, CS Mott Childrens Hosp, Ann Arbor, MI 48109 USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-173549
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia
    Y. Lalami
    M. Paesmans
    M. Aoun
    R. Munoz-Bermeo
    K. Reuss
    S. Cherifi
    C. G. Alexopoulos
    J. Klastersky
    Supportive Care in Cancer, 2004, 12 : 725 - 730
  • [22] G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis
    Lorenz Grigull
    Nicole Pulver
    Lilia Goudeva
    Karl-Walter Sykora
    Christin Linderkamp
    Andreas Beilken
    Kathrin Seidemann
    Hansjörg Schmid
    Karl Welte
    Hans-Gert Heuft
    Supportive Care in Cancer, 2006, 14 : 910 - 916
  • [23] Efficacy of Prophylactic G-CSF in Patients Receiving FOLFIRINOX: A Preliminary Retrospective Study
    Terazawa, Tetsuji
    Goto, Masahiro
    Miyamoto, Takahiro
    Asaishi, Ken
    Shimamoto, Fukutaro
    Kuwakado, Shin
    Nishitani, Hitoshi
    Kii, Takayuki
    Higuchi, Kazuhide
    INTERNAL MEDICINE, 2015, 54 (23) : 2969 - 2973
  • [24] Intermediate dose etoposide plus g-csf is a promising mobilization schedule of PBPC: a retrospective comparison with cyclophosphamide 4 g/m2 plus G-CSF
    Milone, G
    Leotta, S
    Tornello, A
    Murgano, P
    Moschetti, G
    Mercurio, S
    Guido, G
    Indelicato, F
    Consoli, U
    Giustolisi, R
    BONE MARROW TRANSPLANTATION, 2003, 31 : S250 - S251
  • [25] Preliminary results of stem cell mobilization in chronic myeloid leukemia with a moderate intensity chemotherapy regimen and G-CSF or G-CSF plus IL-3
    Aulitzky, WE
    Neubauer, A
    Kolbe, K
    Schneller, F
    Busemann, C
    Schleiermacher, E
    Peschel, C
    Siegert, W
    Huber, C
    Huhn, D
    BONE MARROW TRANSPLANTATION, 1996, 17 : S67 - S69
  • [26] A phase I/II study of multicyclic dose-intensive chemotherapy supported with G-CSF, or G-CSF and haematopoietic progenitor cells in whole blood, in two consecutive cohorts of patients
    de Wit, R
    Kruit, WHJ
    Lamers, CHJ
    van't Veer, MB
    Luyten, AA
    van Beurden, V
    Harteveld, M
    Planting, AST
    Schmitz, PIM
    Stoter, G
    Bolhuis, RLH
    Verweij, J
    BRITISH JOURNAL OF CANCER, 1998, 77 (12) : 2363 - 2366
  • [27] A phase I/II study of multicyclic dose-intensive chemotherapy supported with G-CSF, or G-CSF and haematopoietic progenitor cells in whole blood, in two consecutive cohorts of patients
    R de Wit
    WHJ Kruit
    CHJ Lamers
    MB van 't Veer
    AA Luyten
    V van Beurden
    M Harteveld
    ASTh Planting
    PIM Schmitz
    G Stoter
    RLH Bolhuis
    J Verweij
    British Journal of Cancer, 1998, 77 : 2363 - 2366
  • [28] Comparable efficacy and lower cost of PBSC mobilization with intermediate-dose cyclophosphamide and G-CSF compared with plerixafor and G-CSF in patients with multiple myeloma treated with novel therapies
    Awan, F.
    Kochuparambil, S. T.
    Falconer, D. E.
    Cumpston, A.
    Leadmon, S.
    Watkins, K.
    DeRemer, D.
    Jillella, A.
    Craig, M.
    Hamadani, M.
    BONE MARROW TRANSPLANTATION, 2013, 48 (10) : 1279 - 1284
  • [29] UNEXPECTED FINDINGS IN THE GRANULOCYTE IMMUNOFLUORESCENCE TEST IN PATIENTS TREATED WITH G-CSF
    CHAPMAN, JF
    MURPHY, MF
    EVANS, J
    WATERS, AH
    BRITISH JOURNAL OF HAEMATOLOGY, 1993, 84 : 60 - 60
  • [30] Escalated dose docetaxel (TXT) with G-CSF support in patients (PTS) with solid tumours
    Mitchell, P
    Basser, R
    Ng, S
    Gibbs, P
    Chipman, M
    Grigg, A
    Gargano, J
    Riva, A
    Appia, F
    Green, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S288 - S288
12345